Company Profiles

driven by the PitchBook Platform

Drais Pharmaceuticals

Drais Pharmaceuticals
2007 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series A LATEST DEAL TYPE
$20M LATEST DEAL AMOUNT
$20M TOTAL AMOUNT RAISED
Description

Developer of a drug development platform designed to offer early and mid-stage clinical development. The company's drug development platform addresses unmet medical needs and provides significant benefits over currently available therapies, providing drug development services to virtual companies via vendors and CROs.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
520 US Highway 22
Suite 201
Bridgewater, NJ 08807
United States

+1 (908) 895-1200
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Drais Pharmaceuticals’s full profile, request a free trial.

Drais Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 18-Feb-2010 $20M $20M 0000 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Drais Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00 00 00 00 000
To view this company’s complete Cap Table request access »

Drais Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
InterWest Healthcare Partners Venture Capital Minority 000 0000 000000 0
Sutter Hill Ventures Venture Capital Minority 000 0000 000000 0

Drais Pharmaceuticals Executive Team (9)

Name Title Board
Seat
Contact
Info
Stephen Waters Ph.D Vice President, Nonclinical & Translational Development and Chief Scientific Officer
Christine Mulhauser Director
Deborah Hopper Director, Administration
Christopher Del Mastro Director, Finance & Contracts
Rudy Lucek Executive Vice President, Regulatory Affairs and Quality Control
You’re viewing 5 of 9 executives. Get the full list »

Drais Pharmaceuticals Board Members (3)

Name Representing Role Since Contact
Info
Arnold Oronsky Ph.D InterWest Partners Board Member 000 0000
Jeffrey Bird Ph.D Sutter Hill Ventures Board Member 000 0000
Robert Desjardins MD Drais Pharmaceuticals Board Member 000 0000